AorTech names German heart valve distributor:
This article was originally published in Clinica
Scottish company AorTech has appointed cardiovascular device company MEDOS distributor of its replacement heart valve products in Germany. AorTech says that MEDOS, which has a 15% share of the German cardiopulmonary product market, will market its products to all German open heart centres. The German heart valve replacement market accounts for over a quarter of the European market and is itself the second largest in the world. AorTech's products include the Ultracor mechanical valve, the tissue heart valve and the mitral repair system.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.